Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H28N4O2 |
InChIKeyDMFSPVRZNNUHMU-UHFFFAOYSA-N |
CAS Registry1375560-89-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 05 Apr 2024 |